JODY FRANCISCO: Open Payments
NPI 1659888188 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,801 in 94 payments from 19 companies in 2025. Trend: 2023 $1,175 · 2024 $1,243 · 2025 $1,801
Food & beverage: $1,801
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $304 |
| ABBVIE INC. | 19 | $293 |
| Corium, LLC | 11 | $252 |
| PFIZER INC. | 9 | $145 |
| Antares Pharma, Inc. | 5 | $113 |
| Lilly USA, LLC | 6 | $105 |
| Axsome Therapeutics, Inc. | 3 | $87 |
| SHIELD THERAPEUTICS INC | 3 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| GlaxoSmithKline, LLC. | 4 | $62 |
Products named: Azstarys, QULIPTA, Ozempic, XYOSTED, MOUNJARO, Symbravo, NURTEC ODT, ACCRUFER.
Industry payments across AR — which companies pay providers there.
